Literature DB >> 20350958

Strains of Epstein-Barr virus infecting multiple sclerosis patients.

R M Brennan1, J M Burrows, M J Bell, L Bromham, P A Csurhes, A Lenarczyk, J Sverndal, J Klintenstedt, M P Pender, S R Burrows.   

Abstract

Both epidemiological and experimental studies have indicated that the ubiquitous herpesvirus Epstein-Barr virus (EBV) plays a role in the pathogenesis of multiple sclerosis (MS). Some features of MS epidemiology, such as the decline in risk among migrants from high to low MS prevalence areas, suggest the presence of variant EBV strains that increase MS risk. The objective of this study was to investigate whether genetic variability in EBV is associated with MS. Genes encoding for two EBV antigens (EBNA1 and BRRF2) were sequenced in EBV isolates from 40 MS patients and a similar number of control subjects. These viral antigens were chosen for analysis because they are known to stimulate atypical immune responses in MS. Extensive sequence polymorphism was observed within the EBNA1 and BRRF2 genes in isolates from both MS patients and controls. Interestingly, several single nucleotide polymorphisms within the EBNA1 gene, and one within the BRRF2 gene, were found to occur at marginally different frequencies in EBV strains infecting MS patients versus controls. Although this study does not find a simple causal relationship between EBV strains and the occurrence of MS, the existence of haplotypes that occur at different frequencies in MS patients versus controls may provide an area for future study of the role of EBV strain variation in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20350958     DOI: 10.1177/1352458510364537

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Epstein-Barr virus in oral shedding of children with multiple sclerosis.

Authors:  Carmen Yea; Raymond Tellier; Patrick Chong; Garrett Westmacott; Ruth Ann Marrie; Amit Bar-Or; Brenda Banwell
Journal:  Neurology       Date:  2013-09-06       Impact factor: 9.910

2.  Epstein-Barr virus genetic variants are associated with multiple sclerosis.

Authors:  Rosella Mechelli; Caterina Manzari; Claudia Policano; Anita Annese; Ernesto Picardi; Renato Umeton; Arianna Fornasiero; Anna Maria D'Erchia; Maria Chiara Buscarinu; Cristina Agliardi; Viviana Annibali; Barbara Serafini; Barbara Rosicarelli; Silvia Romano; Daniela F Angelini; Vito A G Ricigliano; Fabio Buttari; Luca Battistini; Diego Centonze; Franca R Guerini; Sandra D'Alfonso; Graziano Pesole; Marco Salvetti; Giovanni Ristori
Journal:  Neurology       Date:  2015-03-04       Impact factor: 9.910

3.  Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APC.

Authors:  Barlas Büyüktimkin; Prakash Manikwar; Paul K Kiptoo; Ahmed H Badawi; John M Stewart; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2012-11-29       Impact factor: 4.939

4.  XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?

Authors:  Kelly Claire Simon; Kassandra L Munger; Alberto Ascherio
Journal:  J Neurol Sci       Date:  2011-10-04       Impact factor: 3.181

Review 5.  The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.

Authors:  Michael P Pender
Journal:  Neuroscientist       Date:  2010-11-12       Impact factor: 7.519

6.  Varicella zoster virus and relapsing remitting multiple sclerosis.

Authors:  Julio Sotelo; Teresa Corona
Journal:  Mult Scler Int       Date:  2011-03-30

Review 7.  Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy.

Authors:  Michael P Pender; Scott R Burrows
Journal:  Clin Transl Immunology       Date:  2014-10-31

8.  Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1,000 Genomes Project.

Authors:  Gabriel Santpere; Fleur Darre; Soledad Blanco; Antonio Alcami; Pablo Villoslada; M Mar Albà; Arcadi Navarro
Journal:  Genome Biol Evol       Date:  2014-04       Impact factor: 3.416

Review 9.  Epstein-Barr Virus and Multiple Sclerosis.

Authors:  Gunnar Houen; Nicole Hartwig Trier; Jette Lautrup Frederiksen
Journal:  Front Immunol       Date:  2020-12-17       Impact factor: 7.561

10.  Prevention of MS Requires Intervention on the Causes of the Disease: Reconciling Genes, Epigenetics, and Epstein Barr Virus.

Authors:  Patrick K A Kearns
Journal:  Front Neurol       Date:  2022-02-22       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.